EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential

Jiabin Duan, Jiaqi Liu, Qingsheng Meng, Jiahao Liu, Sitian Yang, Fang Zhou, Jing Cao iD

The FASEB Journal · 15.09.2026 · 40 (17)

DOI: 10.1096/fj.202602361rr ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 09.09.2026. Verfasst von Jiabin Duan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Sirtuin 1, Neurodegenerative Diseases. Die Arbeit nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: | National Natural Science Foundation of China-Henan Joint Fund (-), Program for Innovative Research Team in Universities of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are characterized by progressive protein aggregation, mitochondrial dysfunction, neuroinflammation, and cognitive decline, yet effective mechanism‐based interventions remain limited. Sirtuin 1 (SIRT1), an NAD + ‐dependent deacetylase, has emerged as a multifunctional regulator linking stress adaptation, proteostasis, and metabolic homeostasis to disease progression. Increasing evidence indicates that SIRT1 supports cognitive resilience by coordinating synaptic plasticity, autophagy–lysosomal function, mitochondrial homeostasis, and inflammatory control. In Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), reduced or dysregulated SIRT1 is associated with protein aggregation, mitochondrial dysfunction, and cognitive decline, although its effects may be disease‐ and stage‐dependent, particularly in HD. This review summarizes the structural and catalytic features of SIRT1, examines the mechanisms linking SIRT1 to cognitive impairment across major neurodegenerative diseases, and evaluates the opportunities and limitations of SIRT1‐targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1Neurodegenerative DiseasesHumansAnimalsMitochondria

Stichwörter der Autor:innen

SIRT1mitochondrial dysfunctionneurodegenerative diseasesneuroinflammationproteostasistherapeutics

Substanzen

Sirtuin 1SIRT1 protein, human

Autor:innen und Institutionen

  • Department of Human Anatomy, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • The First Clinical Medical College of, Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • The Second Clinical Medical College of, Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Occupational and Environmental Health, School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.

ORCID-Profile: Jing Cao

Förderung

  • | National Natural Science Foundation of China-Henan Joint Fund (-)
  • Program for Innovative Research Team in Universities of Henan Province

Zitieren

APA

Duan, J., Liu, J., Meng, Q., Liu, J., Yang, S., Zhou, F., & Cao, J. (2026). SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential. The FASEB Journal, 40(17). https://doi.org/10.1096/fj.202602361rr

Vancouver

Duan J, Liu J, Meng Q, Liu J, Yang S, Zhou F, et al. SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential. The FASEB Journal. 2026;40(17). doi:10.1096/fj.202602361rr

BibTeX
@article{Duan2026,
  author = {Duan, Jiabin and Liu, Jiaqi and Meng, Qingsheng and Liu, Jiahao and Yang, Sitian and Zhou, Fang and Cao, Jing},
  title = {SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {17},
  doi = {10.1096/fj.202602361rr}
}
Kostenlos starten →